Successful treatment of congenital hyperinsulinism with long-acting release octreotide

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 333-339

  Le Quan Sang, Kim Hanh ^a   Arnoux, Jean Baptiste ^a   Mamoune, Asmaa ^a,b   Saint Martin, Cécile ^c   Bellanné Chantelot, Christine ^c   Valayannopoulos, Vassili ^a   Brassier, Anais ^a   Kayirangwa, Honorine ^a,b   Barbier, Valérie ^a   Broissand, Christine ^a   Fabreguettes, Jean Roch ^a   Charron, Brigitte ^a   Thalabard, Jean Christophe ^d   De Lonlay, Pascale ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; OCTREOTIDE; SOMATOMEDIN C;

ABSENCE OF SIDE EFFECTS; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MEDICAL CARE; PATIENT SATISFACTION; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; OCTREOTIDE; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; TREATMENT OUTCOME;

EID: 84856090073     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0874     Document Type: Article

References (29)

1. Filan PM, Inder TE, Cameron FJ, Kean MJ & Hunt RW. Neonatal hypoglycemia and occipital cerebral injury. Journal of Pediatrics 2006 148 552-555. (doi:10.1016/j.jpeds.2005.11.015)
2. Menni F, de Lonlay P, Sevin C, Touati G, Peigné C, Barbier V, Nihoul-Fékété C, Saudubray JM & Robert JJ. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001 107 476-479. (doi:10.1542/peds.107.3.476)
3. Arnoux JB, de Lonlay P, Ribeiro MJ, Hussain K, Blankenstein O, Mohnike K, Valayannopoulos V, Robert JJ, Rahier J, Sempoux C, Bellanné C, Verkarre V, Aigrain Y, Jaubert F, Brunelle F & Nihoul-Fékété C. Congenital hyperinsulinism. Early Human Development 2010 86 287-294. (doi:10.1016/j.earlhumdev.2010.05.003)
4. Hussain K, Blankenstein O, De Lonlay P & Christesen HT. Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Archives of Disease in Childhood 2007 92 568-570. (doi:10.1136/adc.2006.115543)
5. Bellanné-Chantelot C, Saint-Martin C, Ribeiro MJ, Vaury C, Verkarre V, Arnoux JB, Valayannopoulos V, Gobrecht S, Sempoux C, Rahier J, Fournet JC, Jaubert F, Aigrain Y, Nihoul-Fékété C & de Lonlay P. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Journal of Medical Genetics 2010 47 752-759. (doi:10.1136/jmg.2009.075416)
6. de Lonlay P, Fournet JC, Touati G, Martin D, Sevin C, Delagne V, Sempoux C, Brusset C, Laborde C, Vassault A, Rahier J, Junien C, Brunelle F, Nihoul Fékété C, Robert JJ & Saudubray JM. Heterogeneity of persistent hyperinsulinemic hypoglycemia of infancy. A series of 175 cases. European Journal of Pediatrics 2002 161 37-48.
7. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fékété C, Robert JJ & Saudubray JM. Clinical features of 52 neonates with hyperinsulinism. New England Journal of Medicine 1999 340 1169-1175. (doi:10.1056/NEJM199904153401505)
8. Cherian MP & Abduljabbar MA. Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): long-term outcome following 95% pancreatectomy. Journal of Pediatric Endocrinology and Metabolism 2005 18 1441-1448. (doi:10.1515/JPEM. 2005.18.12.1441)
9. Kumaran A, Kapoor RR, Flanagan SE, Ellard S & Hussain K. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks. Hormone Research in Pediatrics 2010 73 287-292. (doi:10.1159/000284394)
10. Glaser B & Landau H. Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy. Digestion 1990 45 27-35. (doi:10.1159/000200258)
11. Glaser B, Hirsch HJ & Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. Journal of Pediatrics 1993 123 644-650. (doi:10.1016/S0022-3476(05)80970-9)
12. Mazor-Aronovitch K, Gillis D, Lobel D, Hirsch HJ, Pinhas-Hamiel O, Modan-Moses D, Glaser B & Landau H. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. European Journal of Endocrinology 2007 157 491-497. (doi:10.1530/EJE-07-0445)
13. Thornton PS, Alter CA, Katz LE, Baker L & Stanley CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. Journal of Pediatrics 1993 123 637-643. (doi:10.1016/S0022-3476(05)80969-2)
14. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul- Fékété C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P & Lindley KJ. Practical management of hyperinsulinism in infancy. Archives of Disease in Childhood. Fetal and Neonatal Edition 2000 82 98-107. (doi:10.1136/fn.82.2.F98)
15. Kapoor RR, Flanagan SE, James C, Shield J, Ellard S & Hussain K. Hyperinsulinaemic hypoglycaemia. Archives of Disease in Childhood 2009 94 450-457. (doi:10.1136/adc.2008.148171)
16. Macmullen CM, Zhou Q, Snider KE, Tewson PH, Becker SA, Aziz AR, Ganguly A, Shyng SL & Stanley CA. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the b-cell sulfonylurea receptor SUR1. Diabetes 2011 60 1797-1804. (doi:10.2337/db10-1631)
17. Manificat S, Dazord A, Cochat P & Nicolas J. Evaluation of the quality of life in pediatrics: how to collect the point of view of children. Archives de Pédiatrie 1997 4 1238-1246. (doi:10.1016/S0929-693X(97)82616- 4)
18. Manificat S, Dazord A, Langue J, Danjou G, Bauche P, Bovet F, Cubells J, Luchelli R, Tockert E & Conway K. Evaluation of the quality of life of infants and very young children: validation of a questionnaire. Multicenter European Study. Archives de Pédiatrie 2000 7 605-614. (doi:10.1016/S0929-693X(00)80127-X)
19. R Development Core Team. In A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2010.
20. Venables WN & Ripley BD. In Modern Applied Statistics with S. Fourth Edition. New York: Springer, 2002.
21. Hothorn T, Hornik K, van de Wie M & Zeileis A. Implementing a class of permutation tests: the coin package. Journal of Statistical Software 2008 28 1-23.
22. Grass P, Marbach P, Bruns C & Lancranjan I. Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships. Metabolism 1996 45 27-30. (doi:10.1016/S0026- 0495(96)90075-X)
23. Astruc B, Marbach P, Bouterfa H, Denot C, Safari M, Vitaliti A & Sheppard M. Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles. Journal of Clinical Pharmacology 2005 45 836-844. (doi:10.1177/0091270005277936)
24. Palladino AA & Stanley CA. A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism. Seminars in Pediatric Surgery 2011 20 32-37. (doi:10.1053/j.sempedsurg.2010.10.008)
25. Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P & Anthony L. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. Journal of Clinical Oncology 1999 17 600-606.
26. Laje P, Halaby L, Adzick NS & Stanley CA. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatric Diabetes 2010 11 142-147. (doi:10.1111/j.1399-5448. 2009.00547.x)
27. Modan-Moses D, Koren I, Mazor-Aronovitch K, Pinhas-Hamiel O & Landau H. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). Journal of Clinical Endocrinology and Metabolism 2011 96 2312-2317. (doi:10.1210/jc.2011-0605)
28. Bakker B & Oostdijk W. Diagnosis and management of congenital hyperinsulinism: a case report. European Journal of Endocrinology 2006 155 S153-S155. (doi:10.1530/eje.1.02266)
29. Wilson ME & Tanner JM. Somatostatin analog treatment slows growth and the tempo of reproductive maturation in female rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 1994 79 495-501. (doi:10.1210/jc.79.2.495)